Orthostatic Intolerance Clinical Trials 2023

Orthostatic Intolerance Clinical Trials 2023

Orthostatic Intolerance research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in orthostatic intolerance clinical trials today.

Orthostatic Intolerance Clinical Trials

Here are the 5 most popular medical studies for orthostatic intolerance

Popular filter options for orthostatic intolerance trials

Postural Orthostatic Tachycardia Syndrome Clinical Trials

View 11 Postural Orthostatic Tachycardia Syndrome medical studies.

POTS Clinical Trials

View 11 POTS medical studies.

Orthostatic Intolerance Clinical Trials With No Placebo

View 15 orthostatic intolerance medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to orthostatic intolerance

What are the top hospitals conducting orthostatic intolerance research?

When it comes to advancing our understanding and treatment of orthostatic intolerance, several hospitals are making significant strides in research. One such institution is Vanderbilt University in Nashville, which has three active clinical trials dedicated to orthostatic intolerance and a total of seven trials since their pioneering investigation began in 1996. Another hub of innovation is the University of Calgary in Canada's bustling city of Calgary, where two ongoing trials are underway alongside their notable achievement of two completed studies since venturing into this field just recently in 2019.

Additionally, Vanderbilt University Medical Center continues the momentum with two ongoing orthostatic intolerance trials that add to their impressive track record comprising three previous investigations since initiating their first trial back in 2007. On the west coast, Simon Fraser University located in Burnaby enters the scene with one active clinical trial for orthostatic intolerance and an ambitious plan for future advancements as they carry out their inaugural study slated for 2023. Lastly, BC Children's Hospital situated amidst Vancouver's thriving medical community also plays a crucial role by actively engaging in one current clinical trial while having achieved another successful endeavor documented during their maiden exploration into orthostatic intolerance treatments recorded last year in 2022.

These esteemed institutions demonstrate unwavering dedication towards addressing the challenges faced by individuals living with orthostatic intolerance. Through continuous scientific inquiry and innovative approaches within these specialized centers across North America, hope shines brighter than ever before for improving the lives of those affected by this condition on a global scale

Which are the best cities for orthostatic intolerance clinical trials?

When it comes to orthostatic intolerance clinical trials, several cities offer opportunities for research and development. Nashville, Tennessee leads the way with 7 active trials focusing on autonomic function tests, saline interventions, and healthy control subjects. Calgary, Alberta follows with 2 ongoing studies investigating all participants and functional electrical stimulation. Burnaby, British Columbia and Vancouver, British Columbia have 1 active trial each exploring counterpressure maneuvers. Lastly, Oklahomag all participants and functional electrical stimulation. Burnaby, British Columbia and Vancouver, British Columbia have 1 active trial each exploring counterpressure maneuvers. Lastly, Oklahoma City, Oklahoma conducts a trial centered around autonomic function tests. These cities provide individuals with orthostatic intolerance an avenue to participate in clinical trials that contribute to advancements in understanding and treating this condition.

Which are the top treatments for orthostatic intolerance being explored in clinical trials?

Orthostatic intolerance, a condition characterized by difficulty in maintaining blood pressure and heart rate when standing up, is currently being investigated for potential treatments through clinical trials. Prominent among these are counterpressure maneuvers, which are being explored in two active trials dedicated to orthostatic intolerance and were first listed in 2022. Another promising treatment option is functional electrical stimulation, under investigation in one ongoing trial since its introduction in 2019. Autonomic function tests also show promise with one active trial focusing on orthostatic intolerance since 2016. Additionally, midodrine has gained attention as a potential treatment option with one ongoing trial and three all-time trials for orthostatic intolerance dating back to 1997. These research efforts aim to improve the lives of individuals dealing with this challenging condition by advancing our understanding of effective therapeutic interventions.

What are the most recent clinical trials for orthostatic intolerance?

Recent clinical trials have been exploring various treatment options for orthostatic intolerance, a condition characterized by the inability to maintain blood pressure and heart rate when standing upright. One promising avenue is the use of stellate ganglion blocks, which involves injecting an anesthetic near the neck to block certain nerve signals that contribute to orthostatic intolerance symptoms. Additionally, normal saline has been investigated as a potential intervention, as it helps replenish fluids and improve blood volume regulation in individuals with this condition. Another study focused on modafinil, a medication known for its wakefulness-promoting properties that may help alleviate symptoms in patients suffering from orthostatic intolerance. These ongoing trials offer hope for improved management and quality of life for those affected by this challenging disorder.

What orthostatic intolerance clinical trials were recently completed?

Vanderbilt University Medical Center recently completed a clinical trial in July 2018 investigating the efficacy of Atomoxetine for orthostatic intolerance. This important study contributes to our understanding of potential treatments for this condition, bringing hope to those suffering from its debilitating symptoms.